“Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo [a, l] pyrene or its diol epoxides”, Proceedings of the National Academy of Sciences, vol. 94, pp. 13542–13547, 1997.,
“Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo [a, l] pyrene”, Chemical research in toxicology, vol. 11, pp. 686–695, 1998.
“Comparison of Cytochrome P450-and Peroxidase-dependent Metabolic Activation of the Potent Carcinogen Dibenzo [a, l] pyrene in Human Cell Lines Formation of Stable DNA Adducts and Absence of a Detectable Increase in Apurinic Sites”, Cancer research, vol. 59, pp. 1412–1416, 1999.,
“Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures”, Chemical research in toxicology, vol. 13, pp. 10–17, 2000.,
“Effects of the (–)-anti-11R, 12S-dihydrodiol 13S, 14R-epoxide of dibenzo [a, l] pyrene on DNA adduct formation and cell cycle arrest in human diploid fibroblasts”, Carcinogenesis, vol. 22, pp. 161–169, 2001.,
“Mutations induced by (?)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells”, Environmental and Molecular Mutagenesis, vol. 41, no. 2, pp. 131 - 139, 2003.,